Cytek Biosciences, Inc.
NASDAQ:CTKB · NASDAQ Global Select
-$0.11 today
Vol 15.69M · Avg 0.88M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+20.83%
Period High
$5.88
Period Low
$3.10
Latest
$3.77
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Avanos Medical, Inc.
NYSE:AVNS
$1.17B
CeriBell, Inc.
NASDAQ:CBLL
$666.01M
Surmodics, Inc.
SRDX
$614.51M
ClearPoint Neuro, Inc.
NASDAQ:CLPT
$529.62M
AngioDynamics, Inc.
NASDAQ:ANGO
$494.59M
OrthoPediatrics Corp.
NASDAQ:KIDS
$472.35M
Varex Imaging Corporation
NASDAQ:VREX
$442.89M
Standard BioTools Inc.
NASDAQ:LAB
$314.36M
Organogenesis Holdings Inc.
NASDAQ:ORGO
$309.46M
Treace Medical Concepts, Inc.
NASDAQ:TMCI
$263.71M
What is the latest CTKB filing?
The latest filing shown is 4 dated Jun 16, 2026.
How many recent filings does CTKB have?
Intrinsic Alpha currently shows 20 recent filings for CTKB.
Explore More
Continue the stock analysis
Jump to another research area for this company.